PATENT CLAIM ANALYSIS

Application Number: 15961618
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["424", "530000"]

Abstract:
Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as cognitive disorders. The methods relate to a regimen of pulsed dosing of blood plasma or blood plasma fractions.

Claim (Index 14):
The method of  claim 1  wherein the Pulse Dosed dosing regimen comprises administering the Plasma Fraction or young plasma for five to seven consecutive days.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.59459
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15499694', '14562401', '15499697', '11473196', '15574795']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7684595938996457
- 35 USC 102 Novelty (BERT): 0.5453581668169794
- Combined Prediction Score: 0.7461494511913791
- Mean Citation Score: 314.247896
- Max Citation Score: 419.28943
- Similarity Product: 260.87539064892053

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test